Hyponatremia in patients treated with lorcainide, a new antiarrhythmic drug
- 1 December 1984
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 108 (6) , 1443-1448
- https://doi.org/10.1016/0002-8703(84)90690-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Clinical and electrophysiologic effects of chronic lorcainide therapy in refractory ventricular tachycardiaJournal of the American College of Cardiology, 1983
- Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.Circulation, 1983
- Rapid and simple method for determination of lorcainide, a new antiarrhythmic drug, and its major metabolite, norlorcainide, by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmiasAmerican Heart Journal, 1982
- Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disordersThe American Journal of Cardiology, 1981